Dietary Treatment of Hypercholestrolemia: Can We Predict Long-Term Success?
Yaakov Henkin, MD and
Iris Shai, PhD
Department of Cardiology, Soroka University Medical Center (Y.H.), Beer-Sheva, ISRAEL
S. Daniel Abraham International Center for Health and Nutrition, Epidemiology and Health Services Evaluation Department, Faculty of Health Sciences Ben-Gurion University of the Negev (I.S.), Beer-Sheva, ISRAEL
View larger version (16K):
[in a new window]
|
Fig. 1. Percent changes in LDL cholesterol throughout 12 months of follow-up in the high (>26) and low ( 26) baseline body mass index (BMI) subgroups. *p = 0.001 for the difference between the two subgroups.
|
|
View larger version (18K):
[in a new window]
|
Fig. 2. Percent changes in LDL cholesterol throughout 12 months of follow-up in the higher ( 4.59mmol/L) and lower (<4.59mmol/L) baseline LDL cholesterol subgroups. *p = 0.001 for the difference between the two subgroups.
|
|
View larger version (17K):
[in a new window]
|
Fig. 3. Percent changes in LDL cholesterol throughout 12 months of follow-up in the high (>11%) and low (11%) baseline saturated fatty acid (SFA) intake subgroups. *p = 0.01 for the difference between the two subgroups.
|
|
View larger version (21K):
[in a new window]
|
Fig. 4. Percent changes in LDL cholesterol throughout 12 months of follow-up in the group of "achievers" (10% decrease in LDL cholesterol at 12 months) and "non-achievers" (<10% decrease in LDL cholesterol at 12 months). *p = 0.03 for the difference between the two subgroups. **p = 0.002 for the difference between the two subgroups.
|
|
Copyright © 2003 by the American College of Nutrition.
